Obesity and diabetes are areas of growing concern across both, developed and developing countries. The rising geriatric population is likely to contribute to an increased prevalence of obesity and diabetes across the global landscape. Biomarker research is likely to facilitate the emergence of novel tools that may be useful for enhanced management of obesity, diabetes and related complications in the near future.

There are several biomarkers that are currently being studied for predicting the risk and progression of several diseases such as type 2 diabetes, diabetic kidney disease, obesity and related disorders. Furthermore, companies are looking to leverage new biomarker-based platforms for early diagnosis and timely clinical management of obesity, diabetes and related complications. Biomarker-based research may also open novel paradigms for drug discovery and development obesity and diabetes disorders.

2. Role of Biomarkers in Diabetes and Obesity Management2.1 Diabetes and Obesity Disorders Contribute to Global Mortality2.2 Biomarker Platforms Lead Diverse Clinical and Research Applications2.3 Metabolomic and Proteomic Biomarker Assays Dominate the Technology Landscape

6. Drug Discovery and Development Applications6.1 Obesity and Diabetes Biomarker Discoveries are Likely to Fuel Novel Therapies6.2 Ongoing Late Phase Clinical Studies are Indicative of the Emerging Potential of Diabetes and Obesity Biomarkers6.3 Biomarkers Likely to Play a Larger Role in Diabetes Management6.4 Companion Diagnostic Platform for Obesity Treatment6.5 Novel Companion Diagnostic Platform for Diabetes Management

7. Strategic Insights and Future Perspectives7.1 Research and Development Partnerships Dominate the Collaborative Landscape7.2 Key Research and Development Partnerships7.3 Key Collaborations for Service Platforms, Product Licensing, and Commercialization7.4 North America Dominates the Regional Landscape for Biomarker Technologies across Diabetes and Obesity Indications7.5 Technology Roadmap

8. Overview of the Patent Landscape8.1 Patent Research Scope and Concepts8.2 Patent Applications for Diabetes and Obesity Biomarkers Likely to Increase in the Future8.3 US Leads the Global Patent Landscape for Diabetes and Obesity Biomarkers8.4 Life Science Companies Dominate the Patent Landscape